BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22863175)

  • 21. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognostic impact of hyponatremia in the ST-elevation myocardial infarction.
    Havránek Š; Bělohlávek J; Škulec R; Kovárník T; Dytrych V; Linhart A
    Scand J Clin Lab Invest; 2011 Feb; 71(1):38-44. PubMed ID: 21091154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of bundle branch block in patients undergoing primary coronary angioplasty in the stent era.
    Vivas D; Pérez-Vizcayno MJ; Hernández-Antolín R; Fernández-Ortiz A; Bañuelos C; Escaned J; Jiménez-Quevedo P; De Agustín JA; Núñez-Gil I; González-Ferrer JJ; Macaya C; Alfonso F
    Am J Cardiol; 2010 May; 105(9):1276-83. PubMed ID: 20403479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry).
    Kang SH; Suh JW; Yoon CH; Cho MC; Kim YJ; Chae SC; Yoon JH; Gwon HC; Han KR; Kim JH; Ahn YK; Jeong MH; Kim HS; Choi DJ;
    Am J Cardiol; 2012 Mar; 109(6):787-93. PubMed ID: 22196789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
    Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
    Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
    Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results].
    Lettieri C; Buffoli F; Romano M; Aroldi M; Baccaglioni N; Tomasi L; Rosiello R; Agostini F; Kuwornu H; Pepi P; Izzo A; Zanini R
    Ital Heart J Suppl; 2005 Sep; 6(9):588-98. PubMed ID: 16281718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population trends in the incidence and outcomes of acute myocardial infarction.
    Yeh RW; Sidney S; Chandra M; Sorel M; Selby JV; Go AS
    N Engl J Med; 2010 Jun; 362(23):2155-65. PubMed ID: 20558366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction.
    Greenberg G; Assali A; Vaknin-Assa H; Brosh D; Teplitsky I; Fuchs S; Battler A; Kornowski R; Lev EI
    Am J Cardiol; 2010 Feb; 105(4):435-40. PubMed ID: 20152235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
    Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
    Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome.
    Taglieri N; Marzocchi A; Saia F; Marrozzini C; Palmerini T; Ortolani P; Cinti L; Rosmini S; Vagnarelli F; Alessi L; Villani C; Scaramuzzino G; Gallelli I; Melandri G; Branzi A; Rapezzi C
    Am J Cardiol; 2011 Jul; 108(1):21-8. PubMed ID: 21529728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hyponatremia (<135 mEq/L) on outcome in patients with non-ST-elevation acute coronary syndrome.
    Singla I; Zahid M; Good CB; Macioce A; Sonel AF
    Am J Cardiol; 2007 Aug; 100(3):406-8. PubMed ID: 17659918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.